69 related articles for article (PubMed ID: 2944576)
21. O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy.
Silber JR; Blank A; Bobola MS; Ghatan S; Kolstoe DD; Berger MS
Clin Cancer Res; 1999 Apr; 5(4):807-14. PubMed ID: 10213216
[TBL] [Abstract][Full Text] [Related]
22. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
Mulcahy RT
Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
[TBL] [Abstract][Full Text] [Related]
23. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
[TBL] [Abstract][Full Text] [Related]
24. O6-methylguanine methyltransferase activity and sensitivity of Japanese tumor cell strains to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)- 3-nitrosourea hydrochloride.
Tsujimura T; Zhang YP; Fujio C; Chang HR; Watatani M; Ishizaki K; Kitamura H; Ikenaga M
Jpn J Cancer Res; 1987 Nov; 78(11):1207-15. PubMed ID: 3121556
[TBL] [Abstract][Full Text] [Related]
25. Immunoaffinity purification of human O6-alkylguanine-DNA alkyltransferase using newly developed monoclonal antibodies.
Brent TP; von Wronski M; Pegram CN; Bigner DD
Cancer Res; 1990 Jan; 50(1):58-61. PubMed ID: 2403418
[TBL] [Abstract][Full Text] [Related]
26. Selection of nitrogen mustard resistance in a rat tumor cell line results in loss of guanine-O6-alkyl transferase activity.
Dean SW; Gibson NW; Tew KD
Mol Pharmacol; 1986 Jul; 30(1):77-80. PubMed ID: 3724747
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of O6-methylguanine-DNA methyltransferase and sensitization of human tumor cells to killing by chloroethylnitrosourea by O6-methylguanine as a free base.
Yarosh DB; Hurst-Calderone S; Babich MA; Day RS
Cancer Res; 1986 Apr; 46(4 Pt 1):1663-8. PubMed ID: 3948156
[TBL] [Abstract][Full Text] [Related]
28. Prevention of 1-(3-deoxycytidyl),2-(1-deoxyguanosinyl)ethane cross-link formation in DNA by rat liver O6-alkylguanine-DNA alkyltransferase.
Ludlum DB; Mehta JR; Tong WP
Cancer Res; 1986 Jul; 46(7):3353-7. PubMed ID: 3708569
[TBL] [Abstract][Full Text] [Related]
29. O6-alkylguanine-DNA alkyltransferase activity in normal human tissues and cells.
Grafstrom RC; Pegg AE; Trump BF; Harris CC
Cancer Res; 1984 Jul; 44(7):2855-7. PubMed ID: 6722814
[TBL] [Abstract][Full Text] [Related]
30. Enhancement by O6-benzyl-N-acetylguanosine derivatives of chloroethylnitrosourea antitumor action in chloroethylnitrosourea-resistant human malignant melanocytes.
Cussac C; Rapp M; Mounetou E; Madelmont JC; Maurizis JC; Godeneche D; Dupuy JM; Sauzieres J; Baudry JP; Veyre A
J Pharmacol Exp Ther; 1994 Dec; 271(3):1353-8. PubMed ID: 7996446
[TBL] [Abstract][Full Text] [Related]
31. Repair of O6-alkylguanine during DNA synthesis in murine bone marrow hematopoietic precursors.
Gerson SL; Trey JE; Miller K; Benjamin E
Cancer Res; 1987 Jan; 47(1):89-95. PubMed ID: 3539320
[TBL] [Abstract][Full Text] [Related]
32. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
Dosch J; Kaina B
Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the rates of repair of O6-alkylguanines in DNA by rat liver and bacterial O6-alkylguanine-DNA alkyltransferase.
Pegg AE; Scicchitano D; Dolan ME
Cancer Res; 1984 Sep; 44(9):3806-11. PubMed ID: 6378375
[TBL] [Abstract][Full Text] [Related]
34. [Mechanisms of cellular resistance to chloroethylnitrosourea in cell lines derived from human brain tumors].
Aida T
Hokkaido Igaku Zasshi; 1988 May; 63(3):348-61. PubMed ID: 3164699
[TBL] [Abstract][Full Text] [Related]
35. Use of oligodeoxynucleotides containing O6-alkylguanine for the assay of O6-alkylguanine-DNA-alkyltransferase activity.
Dolan ME; Scicchitano D; Pegg AE
Cancer Res; 1988 Mar; 48(5):1184-8. PubMed ID: 3342398
[TBL] [Abstract][Full Text] [Related]
36. Antitumor imidazotetrazines--XV. Role of guanine O6 alkylation in the mechanism of cytotoxicity of imidazotetrazinones.
Tisdale MJ
Biochem Pharmacol; 1987 Feb; 36(4):457-62. PubMed ID: 3470008
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment of normal human fibroblasts and human colon carcinoma cells with MNNG allows chloroethylnitrosourea to produce DNA interstrand crosslinks not observed in cells treated with chloroethylnitrosourea alone.
Zlotogorski C; Erickson LC
Carcinogenesis; 1983; 4(6):759-63. PubMed ID: 6861280
[TBL] [Abstract][Full Text] [Related]
38. The relevance of DNA repair in the cytotoxic response of mammalian cells to alkylating agents.
Citti L; Mariani L; Catapano CV; Malvaldi G
Ann Ist Super Sanita; 1989; 25(1):5-9. PubMed ID: 2751197
[TBL] [Abstract][Full Text] [Related]
39. O6-alkylguanine-DNA-alkyltransferase activity and nitrosourea sensitivity in human cancer cell lines.
Walker MC; Masters JR; Margison GP
Br J Cancer; 1992 Nov; 66(5):840-3. PubMed ID: 1419626
[TBL] [Abstract][Full Text] [Related]
40. Recombinant adeno-associated virus-mediated expression of O6-alkylguanine-DNA-alkyltransferase protects human epithelial and hematopoietic cells against chloroethylating agent toxicity.
Longhurst SJ; Rafferty JA; Arrand JR; Cortez N; Giraud C; Berns KI; Fairbairn LJ
Hum Gene Ther; 1999 Jan; 10(2):301-10. PubMed ID: 10022554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
